Logo image of ATAI

ATAI LIFE SCIENCES NV (ATAI) Stock Overview

USA - NASDAQ:ATAI - NL0015000DX5 - Common Stock

4.605 USD
+0.01 (+0.11%)
Last: 9/12/2025, 12:34:53 PM

ATAI Key Statistics, Chart & Performance

Key Statistics
52 Week High5.34
52 Week Low1.03
Market Cap987.04M
Shares214.34M
Float195.20M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.69
PEN/A
Fwd PEN/A
Earnings (Next)11-11 2025-11-11/bmo
IPO06-18 2021-06-18
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


ATAI short term performance overview.The bars show the price performance of ATAI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 50 100 150 200

ATAI long term performance overview.The bars show the price performance of ATAI in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150 200 250

The current stock price of ATAI is 4.605 USD. In the past month the price increased by 13.58%. In the past year, price increased by 253.85%.

ATAI LIFE SCIENCES NV / ATAI Daily stock chart

ATAI Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 46.74 714.48B
JNJ JOHNSON & JOHNSON 17.78 428.25B
AZN ASTRAZENECA PLC-SPONS ADR 17.89 246.21B
NVO NOVO-NORDISK A/S-SPONS ADR 13.94 242.26B
NVS NOVARTIS AG-SPONSORED ADR 13.98 239.47B
MRK MERCK & CO. INC. 10.85 208.74B
PFE PFIZER INC 7.1 136.88B
SNY SANOFI-ADR 10.62 114.96B
BMY BRISTOL-MYERS SQUIBB CO 6.95 95.14B
GSK GSK PLC-SPON ADR 8.96 81.79B
ZTS ZOETIS INC 23.67 65.25B
TAK TAKEDA PHARMACEUTIC-SP ADR 51.88 47.52B

About ATAI

Company Profile

ATAI logo image ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. The company is headquartered in Amstelveen, Noord-Holland and currently employs 54 full-time employees. The company went IPO on 2021-06-18. The firm focused on developing treatments for mental health disorders. The firm's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.

Company Info

ATAI LIFE SCIENCES NV

Prof. J.H.Bavincklaan 7

Amstelveen NOORD-HOLLAND 100022 NL

CEO: Florian Brand

Employees: 54

ATAI Company Website

ATAI Investor Relations

Phone: 31207932536

ATAI LIFE SCIENCES NV / ATAI FAQ

What is the stock price of ATAI LIFE SCIENCES NV today?

The current stock price of ATAI is 4.605 USD. The price increased by 0.11% in the last trading session.


What is the ticker symbol for ATAI LIFE SCIENCES NV stock?

The exchange symbol of ATAI LIFE SCIENCES NV is ATAI and it is listed on the Nasdaq exchange.


On which exchange is ATAI stock listed?

ATAI stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ATAI LIFE SCIENCES NV stock?

15 analysts have analysed ATAI and the average price target is 11.51 USD. This implies a price increase of 149.98% is expected in the next year compared to the current price of 4.605. Check the ATAI LIFE SCIENCES NV stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ATAI LIFE SCIENCES NV worth?

ATAI LIFE SCIENCES NV (ATAI) has a market capitalization of 987.04M USD. This makes ATAI a Small Cap stock.


How many employees does ATAI LIFE SCIENCES NV have?

ATAI LIFE SCIENCES NV (ATAI) currently has 54 employees.


What are the support and resistance levels for ATAI LIFE SCIENCES NV (ATAI) stock?

ATAI LIFE SCIENCES NV (ATAI) has a support level at 4.56 and a resistance level at 4.9. Check the full technical report for a detailed analysis of ATAI support and resistance levels.


Is ATAI LIFE SCIENCES NV (ATAI) expected to grow?

The Revenue of ATAI LIFE SCIENCES NV (ATAI) is expected to grow by 314.74% in the next year. Check the estimates tab for more information on the ATAI EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ATAI LIFE SCIENCES NV (ATAI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ATAI LIFE SCIENCES NV (ATAI) stock pay dividends?

ATAI does not pay a dividend.


When does ATAI LIFE SCIENCES NV (ATAI) report earnings?

ATAI LIFE SCIENCES NV (ATAI) will report earnings on 2025-11-11, before the market open.


What is the Price/Earnings (PE) ratio of ATAI LIFE SCIENCES NV (ATAI)?

ATAI LIFE SCIENCES NV (ATAI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.69).


What is the Short Interest ratio of ATAI LIFE SCIENCES NV (ATAI) stock?

The outstanding short interest for ATAI LIFE SCIENCES NV (ATAI) is 7.85% of its float. Check the ownership tab for more information on the ATAI short interest.


ATAI Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to ATAI. When comparing the yearly performance of all stocks, ATAI is one of the better performing stocks in the market, outperforming 98.4% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ATAI Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to ATAI. While ATAI has a great health rating, there are worries on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ATAI Financial Highlights

Over the last trailing twelve months ATAI reported a non-GAAP Earnings per Share(EPS) of -0.69. The EPS decreased by -72.5% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -78.89%
ROE -103.85%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%61.11%
Sales Q2Q%163.37%
EPS 1Y (TTM)-72.5%
Revenue 1Y (TTM)-1.91%

ATAI Forecast & Estimates

15 analysts have analysed ATAI and the average price target is 11.51 USD. This implies a price increase of 149.98% is expected in the next year compared to the current price of 4.605.

For the next year, analysts expect an EPS growth of 48.51% and a revenue growth 314.74% for ATAI


Analysts
Analysts84
Price Target11.51 (149.95%)
EPS Next Y48.51%
Revenue Next Year314.74%

ATAI Ownership

Ownership
Inst Owners9.44%
Ins Owners2.69%
Short Float %7.85%
Short Ratio2.25